API Suppliers
US DMFs Filed
CEP/COS Certifications
0
JDMFs Filed
0
Other Certificates
0
Other Suppliers
0
0
USA (Orange Book)
0
Europe
0
Canada
0
Australia
0
South Africa
0
Uploaded Dossiers
0
U.S. Medicaid
0
Annual Reports
0
0
USFDA Orange Book Patents
0
USFDA Exclusivities
0
Blog #PharmaFlow
0
News
EDQM
0
USP
0
JP
0
Other Listed Suppliers
0
0
https://www.benzinga.com/pressreleases/22/09/g29091284/zealand-pharma-announces-positive-results-from-phase-3-trial-of-glepaglutide-in-patients-with-shor
https://www.globenewswire.com/news-release/2022/03/11/2401950/0/en/Correction-Zealand-Pharma-Significant-Advancement-of-Clinical-Pipeline-and-Building-Commercial-Momentum-Key-Data-for-Glepaglutide-and-Dasiglucagon-Programs-Expected-in-2022.html
https://www.pharmacompass.com/pdf/news/zealand-pharma-completes-enrollment-in-ease-sbs-1-phase-3-trial-assessing-glepaglutide-in-patients-with-short-bowel-syndrome-1643725656.pdf
https://www.globenewswire.com/news-release/2021/08/19/2283569/0/en/Zealand-Pharma-Announces-First-Patient-Dosed-in-EASE-SBS-4-Phase-3b-Trial-Assessing-Glepaglutide-in-Patients-with-Short-Bowel-Syndrome.html
https://www.globenewswire.com/news-release/2021/06/29/2254571/0/en/Zealand-Pharma-to-Present-Data-on-Glepaglutide-at-the-17th-Congress-of-the-Intestinal-Rehabilitation-and-Transplantation-Association-CIRTA.html